The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming
Article in Frontiers in Immunology (August 2024)
The most recent citing publications are shown below. View all 88 publications that cite this research output on Dimensions.
Toll-like receptor 4 (TLR4) is the major pattern recognition receptor triggering the protective effect of a Candida albicans extracellular vesicle-based vaccine prototype in murine systemic candidiasis
Article in mSphere (July 2024)
Unveiling a Comprehensive Multi-epitope Subunit Vaccine Strategy Against Salmonella subsp. enterica: Bridging Core, Subtractive Proteomics, and Immunoinformatics
Article in Cell Biochemistry and Biophysics (July 2024)